H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 17.7% of adults in Cleveland have diagnosed diabetes — 5.7 points above the U.S. 12% figure. Census population 372,624. Ohio Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Cleveland clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Cleveland storefront.
Wharton's Jelly Allograft Products in Cleveland, OH for clinics & physicians. Wharton's jelly allografts r… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Cleveland is J15 (CGS Administrators) and that adult diabetes here is 17.7% (PLACES 2023), it is selling units, not a program. That is the whartons jelly allograft conversation we actually have.
National Wharton's Jelly Allograft Products notes (how the product actually works)Three grains, kept separate on purpose. City: Census 372,624 and CDC PLACES crude rates. State: Ohio Department of Health, Diabetes Belt counties present. Federal: 21 CFR 1271 and CGS Administrators LCDs. CDC PLACES (2023, crude) estimates 17.7% of adults in Cleveland have diagnosed diabetes — 5.7 points above the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 17.7% of adults in Cleveland have diagnosed diabetes — 5.7 points above the U.S. 12% figure. Adult arthritis here is 28.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Cleveland.
CDC PLACES (2023, crude prevalence) estimates 17.7% of adults — 5.7 points above the U.S. 12% figure. Obesity is 42.2%; arthritis is 28.7%. That is place-level BRFSS modeling, not a clinic census and not a Cleveland trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Ohio compliance risk.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Cleveland clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Bring specialty, monthly joint / regenerative volume, and whether you bill J15 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 17.7% diabetes and 28.7% arthritis for Cleveland — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Cleveland, OH.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Cleveland is J15 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Cleveland — 5.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Ohio Part B wound biologics follow this contractor (siblings: KY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Cleveland. Useful for joint-program math; still needs a diagnosis and privileging.
No Cleveland storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.